2017-11-08
ArkBio and Calibr Announce Joint Development of First-in-Class Chronic Obstructive Pulmonary Disease Drug
ArkBio announced a collaboration with the Calibr to jointly develop novel first-in-class drugs for the treatment of Chronic Obstructive Pulmonary Disease (COPD) and related lung diseases.
know more >